<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13199">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02935088</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10136</org_study_id>
    <nct_id>NCT02935088</nct_id>
  </id_info>
  <brief_title>PRESSUREwire Study</brief_title>
  <official_title>Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand routine use of FFR and alternate indices in
      clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI
      in patients presenting with either stable coronary artery disease, or in patients presenting
      with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during
      index and secondary procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to understand routine use of FFR and alternate indices in
      clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI
      in patients presenting with either stable coronary artery disease, or in patients presenting
      with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during
      index and secondary procedures.

      The study will also collect data on the routine use of coronary physiologic measurements
      such as adenosine-induced hyperemia FFR, FFR by contrast-induced hyperemia,
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterize the 12 month clinical outcomes (MACE) by FFR values and resting indices</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Compare resting indices with FFR values</measure>
    <time_frame>at time of procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Characterize the frequency of change in treatment plan when FFR is used compared to the initial decision based on angiography alone</measure>
    <time_frame>at time of procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Characterize the 12 month clinical outcomes (MACE) in subjects in whom the use of FFR did not lead to a change in treatment decision vs subjects in whom the use of FFR led to a change in treatment decision</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Characterize the 12 month clinical outcomes (MACE) by other PressureWire-derived indices (coronary flow reserve (CFR), index of microcirculatory resistance (IMR), contrast FFR, resistance reserve ratio (RRR)).</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Compare other PressureWire-derived indices (CFR, IMR, contrast FFR, RRR) with FFR values</measure>
    <time_frame>at time of procedure</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Acute Coronary Syndrome</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fractional Flow Reserve</intervention_name>
    <description>Measurement of physiologic parameters</description>
    <other_name>PressureWire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients where FFR has been performed or is planned to be performed for further evaluation
        of PCI procedures, as per physician clinical practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is presenting with STEMI, NSTEMI, unstable angina, or stable coronary artery
             disease

          -  Patient is planned to have FFR performed or underwent a cardiac catheterization where
             FFR was performed for further PCI consideration

          -  Patient signs and dates written informed consent

          -  Patient is eighteen years of age or older at the time of consent

        Exclusion Criteria:

          -  Patient has extremely tortuous or calcified coronary arteries

          -  Patient with a patent coronary artery bypass graft to the target vessel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colin Berry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Glasgow</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maren Wagner</last_name>
    <phone>651-756-5585</phone>
    <email>mwagner2@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Hensley</last_name>
      <email>khensley@theheartcenter.md</email>
    </contact>
    <investigator>
      <last_name>Joshua Krasnow</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Noel, LPN</last_name>
      <phone>321-841-3686</phone>
      <email>henry.noel@orlandohealth.com</email>
    </contact>
    <investigator>
      <last_name>Joel Garcia Fernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clemens Steinwender</last_name>
      <email>clemens.steinwender@akh.linz.at</email>
    </contact>
    <investigator>
      <last_name>Clemens Steinwender</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Lainz</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Christine Leitgeb</last_name>
      <email>maria-christine.leitgeb@extern.wienkav.at</email>
    </contact>
    <investigator>
      <last_name>Georg Delle-Karth</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kliniken der Friedrich-Alexander-Universitat</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sigrun Fechner</last_name>
      <email>sigrun.fechner@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Achenbach</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michalis Lampros</last_name>
      <email>lamprosmichalis@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Michalis Lampros</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milano</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Troiano</last_name>
      <email>sarah.troiano@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Stefano Galli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VU Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvonne Koop</last_name>
      <email>y.koop@vumc.nl</email>
    </contact>
    <investigator>
      <last_name>Niels Van Royen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouw Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <zip>1091 AC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liesbeth Janzen</last_name>
      <email>e.m.janzen@olv.nl</email>
    </contact>
    <investigator>
      <last_name>Liesbeth Janzen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haga Ziekenhuis Locatie Leyenburg</name>
      <address>
        <city>Den Haag</city>
        <zip>2545AA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helga De Lange-Van Bruggen</last_name>
      <email>h.delange-vanbruggen@hagaziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Samer Somi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JoseMaria Aguirre</last_name>
      <email>josemaria.aguirresalcedo@osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>JoseMaria Aguirre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Asistencial Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>09006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Robles</last_name>
      <email>jroblesalonso@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Javier Robles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Jaen</name>
      <address>
        <city>Jaen</city>
        <zip>23007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JuanCarlos Fernandez</last_name>
      <email>jcfgfernandez@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>JuanCarlos Fernandez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 15, 2017</lastchanged_date>
  <firstreceived_date>October 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FFR</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
